Kose Continues Plan to Increase Overseas Sales, but Broadens Focus in Asia Beyond China
With the targets of the Vision 2026 plan interrupted by the pandemic and changes in China consumer appetite, leading to weak 2024 earnings, Kose has revamped its focus. The key components of its ...
How Next-Gen Financial Advisors Are Raising Money to Buy Ownership Stakes Where They Work
The good news for next-generation financial advisors is that valuations of registered investment advisor firms are at a ...
7 Best Socially Responsible Funds
But given the current environment, it is increasingly important to think beyond the standard index funds if you are ...
7 Top-Performing Equal Weight ETFs to Buy Now
These seven equal weight ETFs offer a more balanced approach to superior performance.
Meet America’s Best Large And Midsize Employers 2025
For the 10th straight year, Forbes has ranked the best places to work in the United States based on surveys of more than ...
Remove gender pronouns, says Deloitte US. How big companies are abandoning DEI initiatives
Major corporations including Google, Amazon, McDonald’s, Boeing and IBM have significantly scaled back their diversity, ...
Goldman Sachs Axes Diversity Requirement For Company Boards—Here Are All The Companies Rolling Back DEI
Following Trump's lead, organizations including Walmart, Lowe’s and Meta have announced they would scale back their ...
Why Broadcom Inc. (AVGO) is the Best Long-Term Growth Stock to Buy Now
We recently published a list of the 12 Best Long-Term Growth Stocks to Buy Now. In this article, we are going to take a look ...
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Edwards Lifesciences (EW), Arrowhead Pharmaceuticals (ARWR) and Exelixis (EXEL)
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Edwards Lifesciences (EW – Research Report), Arrowhead ...